Материал: Маркелова Е.В. Персистирующие вирусные инфекции. этиология и иммунопатогенез

145. Aiello, A.E. Population levels of psychological stress, herpesvirus reactivation and HIV / A.E. Aiello, A.M. Simanek, S. Galea // AIDS Behav. – 2010. – V. 14. – P. 308–317.

146. An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in guinea pigs / M. Scoberne, R. Cadin, A. Lee et al. // Journal of Virology. – 2013. – V. 87, №7. – P. 3930–3942.

147.An investigation of ВПГ promoter activity compatible with latency estab-lishment reveals VP 16 independent activation of ВПГ immediate early promoters in sensory neurones / J.T. Proenca, H.M. Coleman, M.P. Nicoll et al. // J. Gen. Virol. – 2011. – V. 92, №11. – P. 2575–2585.

148.Aravalli, R.N. Toll-like receptor 2 signaling is a mediator of apoptosis in herpes simplex virus-infected microglia / R.N. Aravalli, S. Hu, J.R. Lokensgard // J. of Neuroinflammation. – 2007. – Vol. 4. – P. 11.

149.Arduino, P.G. Oral and perioral herpes simplex virus type 1 (ВПГ-

1)infection: review of its management / P.G. Arduino, S.R. Porter // Oral. Dis. – 2010. – V. 12, №3. – P. 254–270.

150.Ashkar, A.A. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection / A.A. Ashkar, K.L. Rosenthal // J. Virol. –2003. –V.77, №18. – P. 10168–10171.

151.Association of Chlamydia trachomatis infection and herpes simplex virus type 2 serostatus with genital human papillomavirus infection in men: the HIM Study / C.J. Alberts, M.F. Schim van der Loeff, M.R. Papenfuss et al. // Sex. Transm. Dis. – 2013. – V. 40, №6. – P. 508–515.

152.Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: Implication for the development of an universal CD8+ T-cell epitope-based vaccine / S. Samandary, H. Kridane-Miledi, J. S. Sandoval et al. // J. Human Immunology. – 2014. – V. 75, №8. – P. 715–729.

153.Association of major histocompatibility complex determinants with the development of symptomatic and asymptomatic genital herpes simplex virus type 2 infections / J.A. Lekstrom-Himes, P. Hohman et al. // J. Infect. Dis. – 1999. – V. 179, №5. – Р. 1077–1085.

154.Association of TLR3-hyporesponsiveness and functional TLR3 L412F polymorphism with recurrent herpes labialis / C.A. Yang, M.J. Raftery, L. Hamann et al. // Human Immunology. – 2012. – V. 73, №8. – P. 844–857.

155.ASP2151 for the treatment of genital herpes: a randomized, doubleblind, placeboand valacyclovir-controlled, dose-finding study / S. Tyring,

A. Wald, N. Zadeikis et al. // J. of infections diseases. – 2012. – V. 205, №7. – P. 1100–1110.

156.Ball, S. C. Persistent herpes simplex virus infection / S.C. Ball // AIDS. Read. – 2001. – V. 11, №5. – P. 249–251.

157.Bloom, D.C. Epigenetic regulation of latent ВПГ-1 gene expression

/D.C. Bloom, N.V.Giordani, D.L. Kwiatkowski // Biochim. Biophys. Acta. – 2010. – V. 1799. – P. 246–256.

158.Bloom, D.C. ВПГ LAT and neuronal survival / D.C. Bloom // Int. ReV.Immunol. – 2004. – V. 23, №1–2. – P. 187–198.

159.Boss, I.W. Role of virus-encoded microRNAs in herpesvirus biology / I.W. Boss, K.B. Plaisance, R. Renne // Trends Microbiol. – 2009. –

V. 17, №12. – P. 544–553.

160.Boyd, A.S. Herpes simplex virus-induced plasmacytic atypia / A.S. Boyd, J.P. Zwerner, J.L. Miller // Cutan. Pathol. – 2012. – V. 39, №2. – P. 270–273.

161.Branco, F.J. Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis / F.J. Branco, N.W. Fraser // Virol. – 2005. – V. 79, №14. – P. 9019–9025.

162.Broketa, M.M. Herpes simplex viruses: biological characteristics, immuno-pathogenesis, diagnosis and treatment / M.M. Broketa, T. Jeren, G. Mlinaric-Galinovic // Lijec. Vjesn. – 2000. – V. 122, №5–6. – P. 140–147.

163.Bryant-Hudson, R.M. PD-L1-expressing dendritic cell contribute to viral resisrance during acute ВПГ-1 infection / R.M. Bryant-Hudson, D.J.J. Carr // Clinical and Developmental Immunology. – 2012. – Article ID 924619. – Р. 9.

164.CD8 T cell control of ВПГ reactivation from latency is abrogated by viral inhibition of MHC class I / M.T. Orr, M.A. Mathis, M. Lagunoff et al. // Cell Host Microbe. – 2007. – V. 13, №2 (3). – P. 172–180.

165.CD8(+) T cells can block herpes simplex virus type 1 (ВПГ-1) reactivation from latency in sensory neurons / T. Liu, K.M. Khanna, X. Chen et al. // J. Exр. Med. – 2000. – V. 191, №9. – P. 1459–1466.

166.CD8(+) T-cell attenuation of cutaneous herpes simplex virus infection reduces the average viral copy number of the ensuing latent infection / L.M. Wakim, C.M. Jones, T. Gebhardt et al. // Immunol. Cell. Biol. – 2008. – V. 86, №8. – P. 666–675.

167.Chakrabarti, S. Regulation of matrix metalloproteinase-9 release from ИЛ-8-stimulated human neutrophils / S. Chakrabarti, K. D Patel. // J. Leukoc. Biol. – 2005. – V. 78. – P. 279–288.

168.Chambers, A. Salivary mediated autoinoculation of herpes simplex virus on the face in the absence of «cold sores», after trauma / A. Chambers, M. Perry // J. Oral Maxillofac. Surg. – 2008. – V. 66, №1. – P. 136–138.

169.Characterization of Herpes Virus Entry Mediator as a Factor inked to Obesty / J. Bassols, J.M. Moreno, F. Ortega et al. // Obesity. – 2010. – V. 18, №2. – P. 239–246.

170.Chentoufi, A.A. Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown / A.A. Chentoufi, E. Kritzer, D.M. Yu // Clinical and Developmental Immunol. – 2012. – V.25, №2. – Р. 1875–1885.

171.Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans / J.L. Pike, T.L. Smith, R.L. Hauger et al. // Psychosom. Med. – 1997. – V. 59, №4. – P. 447–457.

172.Clinical evaluation to confirm the manufacturing consistency of three lots of an adjuvanted glycoprotein D genital herpes vaccine in healthy seronegative pre-teen and adolescent girls: a phase III multi-center doubleblind randomized trial / G. Leroux-Roels, S. Dobson, D. I. Bernstein // Triaks in Vaccinology. – 2013. – V. 2 – P. 10–18.

173.Comparison of the host immune response to herpes simplex virus 1 (ВПГ-1) and ВПГ-2 at two different mucosal sites / M.C. Zheng, C.D. Conrady, J.M. Ward // J. Virol . – 2012. – V. 86, №13. – P. 7454–7458.

174.Comparison of the vaginal microbial communities in women with recurrent genital ВПГ receiving acyclovir intravaginal rings / L.K. Ursell, M. Gunawardana, S. Chang et al. // J. Antiviral Research. – 2014. – V. 102. – P. 87–94.

175.Corey, L. Genital herpes / Sexully Tans. Diseases / [L. Corey, A. Wald]; ed. K. K. Holmes et al. – NY. : McGraw-Hill, 1999. – р. 285–312.

176.Cutaneous lumbosacral Herpes Simplex virus among patients hospitalized for an advanced disease / L. Toutous-Trellu, K.M. Vantieghem, K. Terumalai et al. // J. Eur. Acad. of Dermatol. and Venereol. – 2012. – V. 26, №4. – P. 417–422.

177.Cytokine secretion and latent herpes virus reactivation with 28 days of horizontal hypokinesia / P.N. Uchakin, R.P. Stowe, D. Paddon-Jones et. al. // Aviat. Space. Environ. Med. – 2007. – V. 78, №6. – P. 608–612.

178.Davison, A.J. Evolution of sexually transmitted and sexually transmissible human herpes viruses / A.J. Davison // Ann. N.Y. Acad. – 2011. – V. 1230. – Р. E37–Е49.

179.Delaying the expression of herpes simplex virus type 1 glycoprotein B (gB) to a true late gene alters neurovirulence and inhibits the gB-CD8+ T-cell response in the trigeminal ganglion / S. Ramachandran, K.A. Davoli, M.B. Yee et al. // J. Virol. – 2010. – V. 84, №17. – P. 8811–8820.

180.Divito, S. A triple entente: virus, neurons, and CD8+ T cells maintain ВПГ-1 latency / S. Divito, T.L. Cherpes, R.L. Hendricks // Immunol. Res. – 2006. – V. 36, №1–3. – P. 119–126.

181.Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultues of adult human hepatocytes infected in vitro / S. Rumin, P. Berthillon, E. Tanaka et al. // J. Gen.Virol. – 1999. – V.80, №11. – P. 3007–3018.

182.Effects of herpes simplex virus type 1 infection on immune functions of human neutrophils / S.L. Hung, H.H. Chiang, C.Y. Wu et al. // J. Periodont. Res. – 2012. – V. 47, №5. – P. 635–644.

183.Effects of phosphorylation of herpes simplex virus 1 envelope glycoprotein B by Us3 kinase in vivo and in vitro / T. Imai, K. Sagou, J. Arii,

Y.Kawaguchi // J. Virol. – 2010. – V. 84, №1. – P. 153–162.

184.Epidemiology of orofacial herpes simplex virus infections in the general population in France: results of the HERPI-MAX study / D. Malvy, K. Ezzedine, F. Lancon et al. // J. Eur. Acad. Dermatol. Venereol. – 2007. – V. 21, №10. – P. 1398–1403.

185.Expression of herpes simplex virus 1-encoded microRNAs in human trigeminal ganglia and their relation to local T-cell infiltrates / K. Held, A. Junker, K. Dornmair et al. // Virol. – 2011. – V. 85, №19. – P. 9680–9685.

186.Ferenczy, M.W. Activities of ICP0 involved in the reversal of silencing of quiescent herpes simplex virus 1 / M.W. Ferenczy, D.L. Ranayhossaini, N.A. Deluca // J. Virol. – 2011. – V. 85, №10. – P. 4993–5002.

187.Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1 / P. Lomonte, J. Thomas, P. Texier et al. // J. Virol. – 2004. – V. 78, №13. – P. 6744–6757.

188.Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression / V. Decman, P.R. Kinchington, S.A. Harvey, R.L. Hendricks // J. Virol. – 2005. – V. 79, №16. – P. 10339–10347.

189.Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural

polymorphism and mutations associated with resistance to antivirals / S. Burrel, C. Deback, H. Agut, D. Boutolleau // Antimicrob. Agents Chemother. – 2010. – V. 54, №11. – P. 4833–4842.

190.Glycoprotein G of herpes simplex virus 2 as a novel vaccine antigen for immunity to genital and neurological disease / S. Gorander, H.M. Ali, m. Lindqvist et al. // J. of Virology. – 2012. – V. 86, №14. – P. 7544–7553.

191.Hagglund, R. Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1 / R. Hagglund, B. Roizman // J. Virol. – 2004. –

V. 78, №5. – Р. 2169–2178.

192. Herpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CDld antigen presentation and NKT cell function / P. Rao, H.T. Pham, A. Kulkarni et al. // J. Virol. – 2011. – V. 85, №16. – P. 8093–8104.

193.Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis / E.A. Kurt-Jones, M. Chan, S. Zhou et al.

//Proceedings of the National Academy of Sciences of the United States of America. – 2004. – V. 101, №5. – Р. 1315–1320.

194.Herpes simplex virus antigens directly activate nk cells via tlr2, thus facilitating their presentation to CD4 T lymphocytes / M. Kim, N.R. Osborne, W. Zeng et al. // J. Immunol. – 2012. – V. 188, №9. – P. 4158–4170.

195. Herpes simplex virus infection and risk of atrial fibrillation: a nationwide study / C.-H. Chiang , C.-C. Huang, W.-L. Chan, et al. // International Journal of Cardiology. – 2013. – V. 164. – P. 201–204.

196.Herpes simplex virus type 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cells / G. Alvarez, J. Aldudo, M. Alonso et al. // J. Neuroscience Research. – 2012. – V. 90. – P. 1020–1029.

197.Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity / G. Pollara, K. Speidel, L. Samady et al.

//J. Infect Dis. – 2003. – V. 187, №2. – P. 165–178.

198.Herpes simplex virus reactivation as a complication of photodynamic therapy / S. Nobbe, R.M. Trueb, E. Lars et al. // Photodermatology, Photoimmunology & Photomedicine. – 2011. – V. 27, №1. – P. 51–52.

199.Herpes simplex virus type 1 activates murine natural interferonproducing cells through toll-like receptor 9 / A. Krug, G.D. Luker, W. Barchet et al. // Blood. – 2004. – V. 103, №4. – P. 1433–1437.

200.Herpes simplex virus type-l-induced activation of myeloid dendritic cells: the roles of virus cell interaction and paracrine type I ИФНsecretion / G. Pollara, M. Jones, M.E. Handley et al. // J. of Immunol. – 2004. – V. 173, №6. – P. 4108–4119.

201.Herpes simplex virus US3 protein kinase regulates virus-induced apoptosis in olfactory and vomeronasal chemosensory neurons in vivo / I. Mori, F. Goshima, D. Watanabe et al. // Microbes Infect. – 2006. – Vol. 8, №7. – P. 1806–1812.

202.Herpes zoster following intra-articular corticosteroid injection / N.F. Fer-nandes, R. Malliah, T.P. Stitik, P. Rozdeba // Acta Dermatoven. APA. – 2009. – V. 18, №1. – P. 28–30.

203.Higuchi, H. Complement receptor type 3 (CR3)- and Fc receptor (FcR)-mediated matrix metalloproteinase 9 (MMP-9) secretion and their intracellular signalling of bovine neutrophils / H. Higuchi, M. Ishizaka, H. Nagahata // Vet. Res. Commun. – 2007. – V. 31, №8. – P. 985–991.